宏中药业 (833746.OC)

+ 收藏

财务分析(报告期)(宏中药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 100,844,903.6475,918,572.1244,595,534.3521,926,690.5297,681,527.78-49,363,364.8723,436,387.05
 营业利润(元) 41,499,616.1631,378,962.0219,224,195.9610,184,709.3948,935,464.75-23,226,846.5110,074,506.27
 利润总额(元) 50,025,730.5139,306,357.7123,153,075.4210,114,801.8048,562,771.34-23,232,029.8810,079,689.64
 净利润(元) 44,546,181.0234,241,155.8220,045,333.638,734,794.6346,802,985.53-23,384,777.8110,079,689.64
 归属于母公司股东的净利润(元) 44,546,181.0234,241,155.8220,045,333.638,734,794.6346,802,985.53-23,384,777.8110,079,689.64
盈利能力:
 销售毛利率(%) 64.0864.7865.7465.4267.4264.3262.6755.69
 销售净利率(%) 44.1745.1044.9539.8447.9147.3047.3743.01
 净资产收益率(%) 34.27-19.549.39----
 总资产报酬率ROA(%) 29.11-15.597.22----
 投入资本回报率ROIC(%) 30.0422.9114.886.7546.0371.8627.1711.52
营运能力:
 存货周转率(次) 1.02-0.470.25----
 应收账款周转率(次) 6.10-3.361.85----
 总资产周转率(次) 0.58-0.290.15----
偿债能力:
 资产负债率(%) 27.7732.4632.6029.2922.58-34.4345.90
 股东权益比率(%) 72.2367.5467.4070.7177.42-65.5754.10
 已获利息倍数(倍) 58.1544.9828.5524.4873.13-70.1220.42
 流动比率 1.471.341.152.772.12-1.391.38
 速动比率 0.720.730.401.270.73-0.620.66
发展能力:
 营业收入增长率(%) 3.2416.98-9.66-0.2953.28-81.43198.84
 营业利润增长率(%) -15.202.31-17.231.09128.78-255.071,097.32
 税后利润增长率(%) -4.8211.54-14.28-13.34117.40-256.861,097.78
 净资产增长率(%) 36.90-55.3577.3892.63-135.57101.18
 总资产增长率(%) 46.74-51.1335.7022.96-6.3910.98

前瞻产业研究院